Annals of Clinical Microbiology and Antimicrobials presents its Collection on Microbiome and Infection- Antimicrobial Resistance. This Collection aims to explore the intricate relationship between the microbiome and antimicrobial resistance, focusing on the latest findings and strategies to combat this global health challenge.
Edited by Hakan Leblebicioglu, MD, FESCMID (VM Medical Park Hospital, Turkey) and Timothy McHugh, PhD (University College London, United Kingdom)
The Erratum to this article has been published in Annals of Clinical Microbiology and Antimicrobials 2009 8:31
Annals of Clinical Microbiology and Antimicrobials considers good quality, novel and international articles of more than regional relevance; the journal covers the clinical microbiology of bacteria, viruses and fungi, as well as antimicrobial treatment of infectious diseases in clinical settings.
Research articles must include epidemiological and/or clinical information about isolates; we also welcome systemic reviews, and clinical case reports of high international significance.
We often invite reviews focusing on important current issues, and we also welcome submission of formal systematic reviews. Authors who are considering submitting an unsolicited review should contact the editorial office for advice on the relevance of the content and the quality of evidence that is expected.
Hakan Leblebicioglu, Editor-in-Chief
Professor Leblebicioglu is the former head of the Department of Infectious Diseases and Clinical Microbiology at Ondokuz Mayis University Medical School in Turkey and working at Samsun Liv Hospital, Turkey. He is currently a Fellow of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), a founding member and Honorary Chief of ESCMID Study Group for Infections in Travelers and Migrants (ESGITM) and also a member of the Study Group for Viral Hepatitis (ESGVH). He has authored 162 publications in peer-reviewed international medical journals (H index is 31 in Web of Science), mainly in Crimean Congo hemorrhagic fever, viral hepatitis and healthcare associated infections. He has conducted workshops and courses in the area of effective communication, presentation skills, proposal and manuscript writing.
Tim McHugh, Editor-in-Chief
Professor McHugh leads the UCL Centre for Clinical Microbiology (CCM). Located at the Royal Free Hospital, CCM aims to improve the diagnosis and treatment of infectious diseases and contributes in the areas of antimicrobial resistance, infection in patients with immunosuppression and hospital acquired infection. Prof McHugh has a particular focus on respiratory infection and CCM has activities in all stages of the TB drug development pathway with projects on evaluation of new compounds as well as supporting the laboratory aspects of clinical trials. An underlying theme is the development of biomarkers of treatment outcome, whether transcriptomic analysis of in vitro treatments or the more complex picture of monitoring outcome in patients.
Citation Impact 2023
Journal Impact Factor: 4.6
5-year Journal Impact Factor: 5.3
Source Normalized Impact per Paper (SNIP): 1.413
SCImago Journal Rank (SJR): 1.190
Speed 2023
Submission to first editorial decision (median days): 8
Submission to acceptance (median days): 131
Usage 2023
Downloads: 771,196
Altmetric mentions: 564